MediWound Ltd (MDWD):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:MediWound Ltd (MDWD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9804
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MediWound Ltd (MediWound) is a biopharmaceutical company that on develops, manufactures and commercializes novel therapeutics based on its patented proteolytic enzyme technology. Its products address unmet needs in the areas of severe burns, chronic and other hard-to-heal wounds.The company’s first innovative biopharmaceutical product, NexoBrid is approved for removal of damaged or dead tissue, namely, eschar, in adults with deep partial and full-thickness thermal burns. MediWound has approval to market NexoBrid in the European Union, Israel and Argentina. The company sells NexoBrid in Europe, Israel through its commercial organization and in Argentina, through local distributor. MediWound is headquartered in Yavne, Israel.

MediWound Ltd (MDWD) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MediWound Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MediWound Ltd, Medical Devices Deals, 2012 to YTD 2018 9
MediWound Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
MediWound Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
MediWound Raises US$20 Million In Venture Financing 11
Partnerships 12
MediWound Enters into Distribution Agreement with Holy Stone Healthcare 12
MediWound Enters Distribution Agreement with Avalon Pharma for NexoBrid 13
MediWound Enters Distribution Agreement With Genfa Medica For NexoBrid 14
Licensing Agreements 15
Kaken Pharma Enters into Licensing Agreement with MediWound 15
Equity Offering 16
MediWound Raises USD25.2 Million in Public Offering of Shares 16
MediWound Completes IPO For US$80.5 Million 18
Asset Transactions 20
MediWound to Sell NexoBrid 20
MediWound Ltd – Key Competitors 21
MediWound Ltd – Key Employees 22
MediWound Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Aug 07, 2018: MediWound Reports Second Quarter 2018 Financial Results 24
May 10, 2018: MediWound Reports First Quarter 2018 Financial Results 26
Mar 19, 2018: MediWound Announces Fourth Quarter And Fiscal Year 2017 Financial Results 28
Nov 16, 2017: MediWound Reports Third Quarter 2017 Financial Results 31
Aug 03, 2017: MediWound Reports Second Quarter 2017 Financial Results 33
May 08, 2017: MediWound Reports First Quarter 2017 Financial Results 35
Feb 21, 2017: MediWound Reports 2016 Fourth Quarter and Full Year Financial Results 37
Corporate Communications 39
Oct 25, 2017: MediWound Appoints Mr. Stephen T. Wills as Chairman to its Board of Directors 39
May 18, 2017: MediWound Announces Changes to its Board of Directors 40
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
MediWound Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MediWound Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MediWound Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
MediWound Ltd, Medical Devices Deals, 2012 to YTD 2018 9
MediWound Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
MediWound Raises US$20 Million In Venture Financing 11
MediWound Enters into Distribution Agreement with Holy Stone Healthcare 12
MediWound Enters Distribution Agreement with Avalon Pharma for NexoBrid 13
MediWound Enters Distribution Agreement With Genfa Medica For NexoBrid 14
Kaken Pharma Enters into Licensing Agreement with MediWound 15
MediWound Raises USD25.2 Million in Public Offering of Shares 16
MediWound Completes IPO For US$80.5 Million 18
MediWound to Sell NexoBrid 20
MediWound Ltd, Key Competitors 21
MediWound Ltd, Key Employees 22
MediWound Ltd, Subsidiaries 23

List of Figures
MediWound Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MediWound Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MediWound Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MediWound Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[MediWound Ltd (MDWD):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Orexo AB (ORX):製薬・医療:M&Aディール及び事業提携情報
    Summary Orexo AB (Orexo) is a specialty pharmaceutical company that focuses on the research, formulation, development, registration and commercialization of drugs. The company's commercial product portfolio consists of Abstral, Edluar and Zubsolv. its pipeline candidates comprise OX51 for procedure- …
  • Aevi Genomic Medicine Inc (GNMX):企業の財務・戦略的SWOT分析
    Summary Aevi Genomic Medicine Inc (Aevi), formerly Medgenics Inc is a research and development company that discovers and develops novel therapies for pediatric onset and life-altering diseases.The company provides pipeline products such as AEVI-001 and AEVI-002. Its lead product AEVI-001, is a glut …
  • Fate Therapeutics Inc (FATE):製薬・医療:M&Aディール及び事業提携情報
    Summary Fate Therapeutics Inc (Fate Therapeutics) is a biopharmaceutical company that develops programmed cellular therapies for cancer and immune disorders. The company’s pipeline product candidates include cellular immunotherapy pipeline, immuno-oncology candidates, and immuno-regulatory candidate …
  • Nordstrom Inc (JWN):企業の財務・戦略的SWOT分析
    Nordstrom Inc (JWN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • CMC Materials Inc (CCMP):企業の財務・戦略的SWOT分析
    CMC Materials Inc (CCMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hang Lung Properties Limited:企業の戦略・SWOT・財務情報
    Hang Lung Properties Limited - Strategy, SWOT and Corporate Finance Report Summary Hang Lung Properties Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Polymedco Inc-医療機器分野:企業M&A・提携分析
    Summary Polymedco Inc (Polymedco) is a medical device company that manufactures and markets laboratory instruments, reagents and kits. The company provides FIT testing, ESR testing, chemistry testing instruments, oc-auto fit, oc-lights fit, oc-auto sensor, diana, oc-automicro 80, epi procolon, sedit …
  • Deutsche Borse Ag
    Deutsche Borse Ag - Strategy, SWOT and Corporate Finance Report Summary Deutsche Borse Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Grupo Aeroportuario del Centro Norte SAB de CV:企業の戦略・SWOT・財務情報
    Grupo Aeroportuario del Centro Norte SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Grupo Aeroportuario del Centro Norte SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • First Abu Dhabi Bank (FAB):企業の財務・戦略的SWOT分析
    First Abu Dhabi Bank (FAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • HemaCare Corp (HEMA):企業の財務・戦略的SWOT分析
    Summary HemaCare Corp (HemaCare) is a provider of biological blood products and services. The company offers primary blood cells and tissues derived from normal and mobilized peripheral blood, cord blood, and bone marrow. It spans its expertise in isolations, custom cell collections and testing of p …
  • Inter Pipeline Ltd (IPL):石油・ガス:M&Aディール及び事業提携情報
    Summary Inter Pipeline Ltd (Inter Pipeline) is an integrated energy infrastructure business. The company is involved in petroleum transportation, natural gas liquids (NGLs) processing and storage of bulk liquids. Its energy infrastructure comprises pipeline systems, storage terminals, straddle and o …
  • Husqvarna AB (HUSQ B):企業の財務・戦略的SWOT分析
    Summary Husqvarna AB (Husqvarna) is an industrial equipment company that produces outdoor power products for forestry, gardening and construction. The company offers wheeled products, electric products, handheld products, watering and hand tools, accessories, and construction products, among others. …
  • Datang International Power Generation Co Ltd (991)-エネルギー分野:企業M&A・提携分析
    Summary Datang International Power Generation Company Limited (Datang Power), a subsidiary of China Datang Corporation, is an independent power generation company. It develops power plants; produces and distributes electricity; and sells heat. The company generates electricity from coal-fired genera …
  • Baoye Group Company Limited:企業の戦略・SWOT・財務情報
    Baoye Group Company Limited - Strategy, SWOT and Corporate Finance Report Summary Baoye Group Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • IntelliCell BioSciences Inc:企業の戦略的SWOT分析
    IntelliCell BioSciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Terracon Consultants Inc:企業のM&A・事業提携・投資動向
    Terracon Consultants Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Terracon Consultants Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Lipigon Pharmaceuticals AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Lipigon Pharmaceuticals AB (Lipigon Pharmaceuticals) is a lipid biology company that discovers and develops novel therapies for lipid disorders and other cardiometabolic risk factors. The company offers developing its products in various therapeutic areas such as cardiovascular and metabolic …
  • Inabata & Co Ltd (8098):企業の財務・戦略的SWOT分析
    Inabata & Co Ltd (8098) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Buongiorno SpA:企業の戦略的SWOT分析
    Buongiorno SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆